Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
GILD
Home
/
GILD

NASDAQ
$174.549
$174.549

Overview

Price performance
Low
$168.88
High
$174.94
Market open. Last updated: Nov 4, 2026, 6:16 PM UTC
$
174.55
7.08 (4.23%)
Average, 50 days
$151.77
$140.34
Open
$171.99
Previous close
$167.47
52-week high
$175.65
Oct 30, 2026 (6 days ago)
52-week low
$116.88
Jan 5, 2026 (11 months ago)
49.34%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
216.43B
Volume
4 113 383
Total Return (3M)
28.89%
Total Return (1Y)
41.73%
13.08
Sector
Healthcare
Links
Tags
Healthcare
Drug Manufacturers - General
NASDAQ
US
Website
gilead.com
Socials
About
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.

Frequently asked questions

GILD · Gilead Sciences, Inc.

01What is Gilead Sciences, Inc. stock price today?

The current price of GILD is $174.55 — it has increased by 4.23% since the previous close. Data as of Nov 4, 2026.

02Is Gilead Sciences, Inc. stock price growing?

GILD is up 2.39% over the past week, up 20.44% over the past month and up 41.73% over the past year. The price is above its 200-day moving average of $140.34.

03What do analysts say about GILD stock?

Of the 28 analysts covering Gilead Sciences, Inc., 6 rate it a strong buy, 16 rate it a buy, 5 rate it a hold and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

04What is Gilead Sciences, Inc. market cap?

Gilead Sciences, Inc. has a market capitalization of $216.43B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

05What were Gilead Sciences, Inc. earnings last quarter?

In its most recent quarterly report, Gilead Sciences, Inc. posted earnings of $2.55 per share against an estimate of $2.19, beating expectations by 16.44%. Upcoming reports are listed in the earnings calendar.

06What is Gilead Sciences, Inc. revenue for the last quarter?

Gilead Sciences, Inc. reported revenue of $8.3B in its most recent quarter, which has increased by 6.83% compared with the same quarter a year earlier. Analysts had expected $7.81B.

07Does Gilead Sciences, Inc. pay dividends?

Yes. Gilead Sciences, Inc. pays dividends quarterly. The latest payment of $0.82 per share has a payment date of Dec 30, 2026, which corresponds to a dividend yield of 1.88%.

08How volatile is GILD stock?

In the latest trading session GILD moved between $168.88 and $174.94, a range of 3.47% of its current price.

09What are GILD stock 52-week high and low?

Over the past 52 weeks GILD has traded between $116.88 and $175.65. The current price is 0.63% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.